The Power of Networks: Why Rare Diseases Demand Collaboration
Senior moderator Leigh Hart explores the role of pharmaceutical companies in the Rare Disease Networks, what was planned and how it has worked out. Rare
Senior moderator Leigh Hart explores the role of pharmaceutical companies in the Rare Disease Networks, what was planned and how it has worked out. Rare diseases are far from rare. An estimated 300 to 400 million people live with one, yet their needs are often invisible to health systems, researchers, and the medical sciences industry. […]
Senior moderator Leigh Hart explores the role of pharmaceutical companies in the Rare Disease Networks, what was planned and how it has worked out. Rare
Senior Moderator Andrew Grant explores the capabilities and limitations of AI in qualitative research, sharing first hand insights from an experiment using Google Gemini to
This Chronic Disease Awareness Day patient advocate Roxanne Murray strives to ensure no one is left unseen or unheard in the MS, chronic illness and
Our senior research manager and blog contributor Rachel Barnes is celebrating working with LDA Research for a decade. Here she shares her secrets to successful
Issy Clegg examines healing with pride: What LGBTQ+ activism gave to healthcare – and what’s still missing Despite a history of oppression members of the
This year, World Vitiligo Day 2025 will be celebrating its 15th anniversary at an AI-focused summit in Toronto, Canada. The theme is ‘Innovation for Every
